HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 08-MAR-19 6JMD TITLE CRYSTAL STRUCTURE OF HUMAN DHODH IN COMPLEX WITH INHIBITOR 1223 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: DHODEHASE,DIHYDROOROTATE OXIDASE; COMPND 5 EC: 1.3.5.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DHODH; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS DHODH, INHIBITOR, COMPLEX, OXIDOREDUCTASE, OXIDOREDUCTASE- KEYWDS 2 OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.YU,Q.CHEN REVDAT 3 27-MAR-24 6JMD 1 REMARK REVDAT 2 30-SEP-20 6JMD 1 JRNL REVDAT 1 18-MAR-20 6JMD 0 JRNL AUTH Z.ZUO,X.LIU,X.QIAN,T.ZENG,N.SANG,H.LIU,Y.ZHOU,L.TAO,X.ZHOU, JRNL AUTH 2 N.SU,Y.YU,Q.CHEN,Y.LUO,Y.ZHAO JRNL TITL BIFUNCTIONAL NAPHTHO[2,3- D ][1,2,3]TRIAZOLE-4,9-DIONE JRNL TITL 2 COMPOUNDS EXHIBIT ANTITUMOR EFFECTS IN VITRO AND IN VIVO BY JRNL TITL 3 INHIBITING DIHYDROOROTATE DEHYDROGENASE AND INDUCING JRNL TITL 4 REACTIVE OXYGEN SPECIES PRODUCTION. JRNL REF J.MED.CHEM. V. 63 7633 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 32496056 JRNL DOI 10.1021/ACS.JMEDCHEM.0C00512 REMARK 2 REMARK 2 RESOLUTION. 1.78 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.4_1496 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.78 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.45 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 56052 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.155 REMARK 3 R VALUE (WORKING SET) : 0.155 REMARK 3 FREE R VALUE : 0.177 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.040 REMARK 3 FREE R VALUE TEST SET COUNT : 1145 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.4677 - 3.5614 1.00 7190 144 0.1641 0.1727 REMARK 3 2 3.5614 - 2.8269 1.00 6964 152 0.1418 0.1836 REMARK 3 3 2.8269 - 2.4696 1.00 6884 161 0.1436 0.1827 REMARK 3 4 2.4696 - 2.2438 1.00 6870 147 0.1394 0.1672 REMARK 3 5 2.2438 - 2.0829 1.00 6925 114 0.1463 0.1780 REMARK 3 6 2.0829 - 1.9601 1.00 6831 119 0.1590 0.1703 REMARK 3 7 1.9601 - 1.8620 1.00 6794 163 0.1748 0.1698 REMARK 3 8 1.8620 - 1.7809 0.95 6449 145 0.2028 0.1967 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 15.700 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2995 REMARK 3 ANGLE : 1.098 4066 REMARK 3 CHIRALITY : 0.040 444 REMARK 3 PLANARITY : 0.006 531 REMARK 3 DIHEDRAL : 14.532 1125 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6JMD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 14-MAR-19. REMARK 100 THE DEPOSITION ID IS D_1300011369. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-AUG-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56535 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.780 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 10.00 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.78 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.82 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HEPES PH4.6, 2M AMMONIUM SULPHATE, 30% REMARK 280 GLYCEROL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.11267 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 41.05633 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 41.05633 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 82.11267 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 170 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14700 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 31 REMARK 465 THR A 32 REMARK 465 ARG A 396 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 319 O HOH A 501 2.12 REMARK 500 O HOH A 531 O HOH A 727 2.15 REMARK 500 O HOH A 674 O HOH A 717 2.17 REMARK 500 O HOH A 711 O HOH A 712 2.17 REMARK 500 O HOH A 502 O HOH A 625 2.18 REMARK 500 O HOH A 725 O HOH A 734 2.18 REMARK 500 O HOH A 743 O HOH A 751 2.18 REMARK 500 O HOH A 665 O HOH A 750 2.18 REMARK 500 O HOH A 664 O HOH A 755 2.19 REMARK 500 O HOH A 510 O HOH A 634 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 41 -62.39 -131.32 REMARK 500 ASP A 99 79.12 -110.47 REMARK 500 ASN A 284 -174.12 -69.82 REMARK 500 TYR A 356 -63.69 -141.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FMN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ORO A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue LDA A 407 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BVO A 408 DBREF 6JMD A 31 396 UNP Q02127 PYRD_HUMAN 30 395 SEQRES 1 A 366 ALA THR GLY ASP GLU ARG PHE TYR ALA GLU HIS LEU MET SEQRES 2 A 366 PRO THR LEU GLN GLY LEU LEU ASP PRO GLU SER ALA HIS SEQRES 3 A 366 ARG LEU ALA VAL ARG PHE THR SER LEU GLY LEU LEU PRO SEQRES 4 A 366 ARG ALA ARG PHE GLN ASP SER ASP MET LEU GLU VAL ARG SEQRES 5 A 366 VAL LEU GLY HIS LYS PHE ARG ASN PRO VAL GLY ILE ALA SEQRES 6 A 366 ALA GLY PHE ASP LYS HIS GLY GLU ALA VAL ASP GLY LEU SEQRES 7 A 366 TYR LYS MET GLY PHE GLY PHE VAL GLU ILE GLY SER VAL SEQRES 8 A 366 THR PRO LYS PRO GLN GLU GLY ASN PRO ARG PRO ARG VAL SEQRES 9 A 366 PHE ARG LEU PRO GLU ASP GLN ALA VAL ILE ASN ARG TYR SEQRES 10 A 366 GLY PHE ASN SER HIS GLY LEU SER VAL VAL GLU HIS ARG SEQRES 11 A 366 LEU ARG ALA ARG GLN GLN LYS GLN ALA LYS LEU THR GLU SEQRES 12 A 366 ASP GLY LEU PRO LEU GLY VAL ASN LEU GLY LYS ASN LYS SEQRES 13 A 366 THR SER VAL ASP ALA ALA GLU ASP TYR ALA GLU GLY VAL SEQRES 14 A 366 ARG VAL LEU GLY PRO LEU ALA ASP TYR LEU VAL VAL ASN SEQRES 15 A 366 VAL SER SER PRO ASN THR ALA GLY LEU ARG SER LEU GLN SEQRES 16 A 366 GLY LYS ALA GLU LEU ARG ARG LEU LEU THR LYS VAL LEU SEQRES 17 A 366 GLN GLU ARG ASP GLY LEU ARG ARG VAL HIS ARG PRO ALA SEQRES 18 A 366 VAL LEU VAL LYS ILE ALA PRO ASP LEU THR SER GLN ASP SEQRES 19 A 366 LYS GLU ASP ILE ALA SER VAL VAL LYS GLU LEU GLY ILE SEQRES 20 A 366 ASP GLY LEU ILE VAL THR ASN THR THR VAL SER ARG PRO SEQRES 21 A 366 ALA GLY LEU GLN GLY ALA LEU ARG SER GLU THR GLY GLY SEQRES 22 A 366 LEU SER GLY LYS PRO LEU ARG ASP LEU SER THR GLN THR SEQRES 23 A 366 ILE ARG GLU MET TYR ALA LEU THR GLN GLY ARG VAL PRO SEQRES 24 A 366 ILE ILE GLY VAL GLY GLY VAL SER SER GLY GLN ASP ALA SEQRES 25 A 366 LEU GLU LYS ILE ARG ALA GLY ALA SER LEU VAL GLN LEU SEQRES 26 A 366 TYR THR ALA LEU THR PHE TRP GLY PRO PRO VAL VAL GLY SEQRES 27 A 366 LYS VAL LYS ARG GLU LEU GLU ALA LEU LEU LYS GLU GLN SEQRES 28 A 366 GLY PHE GLY GLY VAL THR ASP ALA ILE GLY ALA ASP HIS SEQRES 29 A 366 ARG ARG HET FMN A 401 50 HET ORO A 402 11 HET SO4 A 403 5 HET SO4 A 404 5 HET ACT A 405 7 HET ACT A 406 7 HET LDA A 407 47 HET BVO A 408 44 HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM ORO OROTIC ACID HETNAM SO4 SULFATE ION HETNAM ACT ACETATE ION HETNAM LDA LAURYL DIMETHYLAMINE-N-OXIDE HETNAM BVO 3-[3,5-BIS(FLUORANYL)-4-[3-(HYDROXYMETHYL) HETNAM 2 BVO PHENYL]PHENYL]BENZO[F]BENZOTRIAZOLE-4,9-DIONE HETSYN FMN RIBOFLAVIN MONOPHOSPHATE FORMUL 2 FMN C17 H21 N4 O9 P FORMUL 3 ORO C5 H4 N2 O4 FORMUL 4 SO4 2(O4 S 2-) FORMUL 6 ACT 2(C2 H3 O2 1-) FORMUL 8 LDA C14 H31 N O FORMUL 9 BVO C23 H13 F2 N3 O3 FORMUL 10 HOH *272(H2 O) HELIX 1 AA1 GLY A 33 HIS A 41 1 9 HELIX 2 AA2 HIS A 41 LEU A 50 1 10 HELIX 3 AA3 ASP A 51 LEU A 65 1 15 HELIX 4 AA4 SER A 76 GLU A 80 5 5 HELIX 5 AA5 ALA A 104 MET A 111 1 8 HELIX 6 AA6 PRO A 138 ASP A 140 5 3 HELIX 7 AA7 GLY A 153 ALA A 163 1 11 HELIX 8 AA8 ARG A 164 ASP A 174 1 11 HELIX 9 AA9 ASP A 190 GLY A 203 1 14 HELIX 10 AB1 PRO A 204 ALA A 206 5 3 HELIX 11 AB2 GLY A 220 GLN A 225 5 6 HELIX 12 AB3 GLY A 226 GLY A 243 1 18 HELIX 13 AB4 LEU A 244 ARG A 249 5 6 HELIX 14 AB5 THR A 261 GLY A 276 1 16 HELIX 15 AB6 LEU A 309 THR A 324 1 16 HELIX 16 AB7 SER A 338 GLY A 349 1 12 HELIX 17 AB8 TYR A 356 GLY A 363 1 8 HELIX 18 AB9 PRO A 365 GLN A 381 1 17 HELIX 19 AC1 GLY A 385 ILE A 390 1 6 HELIX 20 AC2 GLY A 391 ARG A 395 5 5 SHEET 1 AA1 2 VAL A 81 VAL A 83 0 SHEET 2 AA1 2 HIS A 86 PHE A 88 -1 O PHE A 88 N VAL A 81 SHEET 1 AA2 9 VAL A 92 ILE A 94 0 SHEET 2 AA2 9 PHE A 115 VAL A 121 1 O PHE A 115 N ILE A 94 SHEET 3 AA2 9 LEU A 178 LEU A 182 1 O GLY A 179 N VAL A 116 SHEET 4 AA2 9 TYR A 208 ASN A 212 1 O VAL A 210 N LEU A 182 SHEET 5 AA2 9 ALA A 251 ILE A 256 1 O ALA A 251 N LEU A 209 SHEET 6 AA2 9 GLY A 279 VAL A 282 1 O ILE A 281 N VAL A 254 SHEET 7 AA2 9 ILE A 330 VAL A 333 1 O ILE A 331 N LEU A 280 SHEET 8 AA2 9 LEU A 352 LEU A 355 1 O LEU A 352 N GLY A 332 SHEET 9 AA2 9 VAL A 92 ILE A 94 1 N GLY A 93 O VAL A 353 SHEET 1 AA3 3 VAL A 134 LEU A 137 0 SHEET 2 AA3 3 ALA A 142 ASN A 145 -1 O ALA A 142 N LEU A 137 SHEET 3 AA3 3 GLY A 303 GLY A 306 -1 O GLY A 303 N ASN A 145 CISPEP 1 GLY A 119 SER A 120 0 4.39 CISPEP 2 ARG A 131 PRO A 132 0 -4.43 CISPEP 3 VAL A 282 THR A 283 0 12.27 SITE 1 AC1 24 ALA A 95 ALA A 96 GLY A 97 LYS A 100 SITE 2 AC1 24 SER A 120 ASN A 145 ASN A 181 ASN A 212 SITE 3 AC1 24 LYS A 255 THR A 283 ASN A 284 THR A 285 SITE 4 AC1 24 SER A 305 GLY A 306 LEU A 309 VAL A 333 SITE 5 AC1 24 GLY A 334 GLY A 335 LEU A 355 TYR A 356 SITE 6 AC1 24 THR A 357 ORO A 402 HOH A 563 HOH A 565 SITE 1 AC2 11 LYS A 100 ASN A 145 TYR A 147 GLY A 148 SITE 2 AC2 11 PHE A 149 ASN A 212 SER A 215 ASN A 217 SITE 3 AC2 11 ASN A 284 THR A 285 FMN A 401 SITE 1 AC3 4 ARG A 245 VAL A 247 HIS A 248 HOH A 556 SITE 1 AC4 6 ALA A 219 GLY A 220 ARG A 222 HOH A 507 SITE 2 AC4 6 HOH A 517 HOH A 639 SITE 1 AC5 7 GLN A 168 ALA A 169 THR A 172 LEU A 205 SITE 2 AC5 7 ASP A 207 HOH A 510 HOH A 583 SITE 1 AC6 3 ARG A 160 HOH A 695 HOH A 753 SITE 1 AC7 16 GLU A 139 ASP A 140 GLN A 141 PRO A 290 SITE 2 AC7 16 LYS A 307 PRO A 308 ASP A 311 LEU A 312 SITE 3 AC7 16 THR A 314 GLN A 315 ARG A 318 GLU A 344 SITE 4 AC7 16 ARG A 347 ASP A 393 HOH A 648 HOH A 654 SITE 1 AC8 16 TYR A 38 MET A 43 LEU A 46 GLN A 47 SITE 2 AC8 16 PRO A 52 ALA A 55 HIS A 56 LEU A 58 SITE 3 AC8 16 ALA A 59 THR A 63 LEU A 67 LEU A 68 SITE 4 AC8 16 VAL A 134 ARG A 136 TYR A 356 THR A 360 CRYST1 90.627 90.627 123.169 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011034 0.006371 0.000000 0.00000 SCALE2 0.000000 0.012741 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008119 0.00000